$2.43
-0.08-3.19%
Last update: Nov 10, 4:00 PM
Protara Therapeutics Inc
TARANASDAQ
The average analyst price target for Protara Therapeutics is $22.64, 831.7% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $12 to $28. The latest change came on May 20, 2026, when Oppenheimer raised its price target on Protara Therapeutics from $25 to $28 and kept an Outperform rating.
Price Target Range — 9 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
